Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,927 shares at $244.94 ($711K) on 2020-02-18, disclosed to the SEC on 2020-02-19.
Open-market sale of $711k VRTX by EVP and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.50 | 944 | $228K | 32.1% |
| 2 | $241.71 | 120 | $29K | 4.1% |
| 3 | $242.62 | 540 | $131K | 18.4% |
| 4 | $242.62 | 540 | $131K | 18.4% |
| 5 | $243.76 | 134 | $33K | 4.6% |
| 6 | $244.94 | 260 |
| $64K |
| 9.0% |
| 7 | $244.94 | 260 | $64K | 9.0% |
| 8 | $245.75 | 129 | $32K | 4.5% |
| Total | $242.82 avg | 2,927 | $711K | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |